logo
Select company
Select metric
-53879.07%EBITDA Margin
VS
Market
1
Sector
3
Industry
-
History
20
$ 0.39Close
$ 0.09 - $ 2.94 52-Week Range
Ticker Information

Ticker

IXHL

Company Name

INCANNEX HEALTHCARE INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

INCANNEX HEALTHCARE INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IXHL - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -46.34M-53879.07%$ 86K
3/31/2025$ -21.16M-21594.9%$ 98K
12/31/2024$ -23.34M-23812.24%$ 98K
9/30/2024$ 00%$ 86K
6/30/2024$ -18.33M-152716.67%$ 12K
12/31/2023$ 00%$ 0
6/30/2023$ 00%$ 0
12/31/2022$ 00%$ 788.65K
6/30/2022$ 00%$ 788.65K
6/30/2021$ -11.37M-576.32%$ 1.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INCANNEX HEALTHCARE INC's latest trailing twelve months (TTM) EBITDA % stands at -776.62%.
  • Over the past 5 years, INCANNEX HEALTHCARE INC's average EBITDA % has been -42225.97%.
  • The median EBITDA % for INCANNEX HEALTHCARE INC during this period was -22703.57%
  • INCANNEX HEALTHCARE INC reached its highest EBITDA % over the past 5 years at -576.32%.
  • The lowest EBITDA % recorded by INCANNEX HEALTHCARE INC in the same timeframe -152716.67%

INCANNEX HEALTHCARE INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
LYEL : LYELL IMMUNOPHARMA INC -594556.6%CTOR : CITIUS ONCOLOGY INC -SERA : SERA PROGNOSTICS INC -28943.52%STEX : STREAMEX CORP -194653.85%INMB : INMUNE BIO INC -111016%TIL : INSTIL BIO INC -NVCT : NUVECTIS PHARMA INC -TLPH : TALPHERA INC -41870.37%CV : CAPSOVISION INC -CBIO : CRESCENT BIOPHARMA INC -

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for INCANNEX HEALTHCARE INC is calculated as follows: EBITDA [ $ -4.7M ] / Revenues [ $ 604.88K ]
(=) EBITDA % [ -776.62% ]

IXHL - EBITDA Margin, Last 5 years

-152716.67%

Minimum

Jun 30, 2024

-576.32%

Maximum

Jun 30, 2021

-42225.97%

Average

-22703.57%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%